<DOC>
	<DOCNO>NCT00030563</DOCNO>
	<brief_summary>RATIONALE : Radiofrequency ablation use high-frequency electric current kill tumor cell . Combining radiofrequency ablation surgery may kill tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Giving chemotherapy drug surgery radiofrequency ablation may kill remain tumor cell . PURPOSE : Phase II trial determine effectiveness surgery without radiofrequency ablation follow irinotecan treating patient colorectal cancer metastatic liver .</brief_summary>
	<brief_title>Surgery With Without Radiofrequency Ablation Followed Irinotecan Treating Patients With Colorectal Cancer That Metastatic Liver</brief_title>
	<detailed_description>OBJECTIVES : - Determine disease-free survival patient hepatic metastasis primary colorectal carcinoma treat surgical resection without radiofrequency ablation follow irinotecan . - Determine overall survival patient treat regimen . - Determine treatment-related toxicity regimen patient . - Correlate measurement molecular marker clinical outcome patient treat regimen . OUTLINE : This multicenter study . Patients stratify accord treatment radiofrequency ablation addition resection ( yes v ) . Patients undergo surgical resection without radiofrequency ablation . Beginning 4-8 week surgery , patient receive irinotecan IV 90 minute day 1 . Chemotherapy repeat every 3 week total 6 course absence disease progression unacceptable toxicity . Patients follow 4 week , every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 70 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary colorectal adenocarcinoma Hepatic metastasis consider completely resectable No 4 metastasis dual phase CT scan OR Hepatic metastasis completely resectable amenable complete destruction resection radiofrequency ablation More 4 metastasis allow disease resect destroyed situ radiofrequency ablation No extrahepatic disease location No recurrent second primary colorectal cancer colonoscopy within past year Received prior adjuvant chemotherapy fluorouracilbased regimen last dose least 1 month prior surgery No prior radiofrequency ablation residual viable intrahepatic disease CT scan No plan treat radiofrequency ablation alone without surgical resection PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) AST ALT great 5 time ULN No Gilbert 's disease know defect hepatic conjugation glucuronidation Renal : Creatinine great 1.5 time ULN Cardiovascular : No myocardial infarction within past 6 month No congestive heart failure require therapy Other : Not pregnant nursing Fertile patient must use effective contraception 30 day study No malignancy within past 5 year except inactive nonmelanoma skin cancer carcinoma situ cervix No active serious infection No serious underlie medical condition severe concurrent disease would preclude study participation No dementia , significantly alter mental status , psychiatric illness would preclude study participation No known hypersensitivity irinotecan No known infection HIV AIDS No uncontrolled diabetes mellitus No history seizures No drug alcohol abuse within past year PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No prior irinotecan Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy 30 % bone marrow No prior radiotherapy liver At least 3 month since prior radiotherapy pelvis area Surgery : See Disease Characteristics No prior resection hepatic metastasis ( wedge biopsy allow ) Other : No concurrent phenytoin , phenobarbital , antiepileptic medication No concurrent enrollment investigational drug trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>liver metastasis</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>